The distinction between lesional and non-lesional skin in psoriasis vulgaris through expression of adhesion molecules ICAM-1 and VCAM-1

Medical Hypotheses

Volumn 72, Issue 3, 2009, Pages 327-329

  Cabrijan, Leo ^a   Batinac, Tanja ^a   Lenkovic, Maja ^a   Gruber, Franjo ^a  

^a KBC RIJEKA   (Croatia)

Author keywords

[No Author keywords available]

Indexed keywords

INTERCELLULAR ADHESION MOLECULE 1; LYMPHOCYTE FUNCTION ASSOCIATED ANTIGEN 1; VASCULAR CELL ADHESION MOLECULE 1; VERY LATE ACTIVATION ANTIGEN 4;

ANGIOGENESIS; ARTICLE; CONTROLLED STUDY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PSORIASIS VULGARIS; SKIN DEFECT;

BIOLOGICAL MARKERS; DIAGNOSIS, DIFFERENTIAL; GENE EXPRESSION PROFILING; HUMANS; INTERCELLULAR ADHESION MOLECULE-1; PSORIASIS; SKIN; VASCULAR CELL ADHESION MOLECULE-1;

EID: 59249092084     PISSN: 03069877     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mehy.2008.06.049     Document Type: Article

References (22)

1. Hisashi W., and Masahiro T. E-selectin and vascular cell adhesion molecule-1 are critical for initial trafficking of helper-inducer/memory T cells in psoriatic plaques. Arch Dermatol 130 (1994) 457-463
2. Growes W., Ross l., Bsc J., Barker N., and Donald M. Vascular cell adhesion molecule-1: expression in normal and diseased skin and regulation in vivo by interferon gamma m. J Am Acad Dermatol (1993) 67-72
3. Duvic M., Asanao A., Hager C., and Mays S. The pathogenesis of psoriasis and the mechanism of action of tazarotene. J Am Acad Dermatol 129 (1998) 132
4. Springer T.A. Adhesion receptors of immune system. Nature 346 (1990) 425-434
5. Butcher E.C. Leukocyte-endothelial cell recognition. Cell 67 (1991) 1033-1036
6. Pranab K., De Boer O.J., Visser A., Verhagen C.E., Bos J.D., and Pals S.T. Differential expression of ICAM-1, E-selectin and VCAM-1 by endothelial cells in psoriasis and contact dermatitis. Acta Dermatol Venerol 186 (1994) 21-22
7. Terajima S., Higaki M., Igarashi Y., Nogita T., and Kawashima M. An important role of tumor necrosis factor-alpha in the induction of adhesion molecules in psoriasis. Arch Dermatol Res 290 (1998) 246-252
8. Nickoloff B., Mitra R., Green J., Zheng X., Shimizu Y., Thimpson C., et al. Accessory cell function of keratinocytes for superantigens-dependence on lymphocyte function associated antigen-1/Intercellular adhesion molecule-1 interaction. J Immunol 150 (1993) 2148-2159
9. Veale D., Rogers S., and Fitzgerald O. Immunolocalisation of adhesion molecules in psoriatic arthritis, psoriatic and normal skin. Br J Dermatol 132 (1995) 32-38
10. Paukkonen K., and Naukkarinen A. The development of manifest psoriatic lesions is linked with the appearance of ICAM-1 positivity on keratinocytes. Arch Dermatol Res 287 (1995) 165-170
11. Vugmeyster L., Kikuchi T., Lowes M.A., Chamian F., Kagen M., Gilleaudeau P., et al. Falizumab [anti-CD11a]-induced increase in peripheral blood leukocytes in psoriasis patients is preferentially mediated by altered trafficking of memory CD8+ T cells into lesional skin. Clin Immunol 113 (2004) 38-46
12. Boer J., Wakelkamp J., Pals T., Bos D., and Das K. Increased expression of adhesion receptors in both lesional and non-lesional psoriatic skin. Arch Dermatol Res 286 (1994) 304-311
13. Lowes M.A., Turton J.A., Krueger J.G., and Barnetson R.S.t.C. Psoriasis vulgaris flare during afelizumab therapy does not preclude future use: a case series. Bio Med Central 5 (2005) 9
14. DeBoer O.J., Verhagen E.C., Visser A., Bos J.D., and Pranab K.D. Cellular interactions and adhesion molecules in psoriatic skin. Acta Dermatol Venerol 186 (1994) 15-18
15. Buske-Kirschbaum A., Kern S., Ebrecht M., and Hellhammer D.H. Altered distribution of leukocytes subsets and cytokine production in response to acute psychological stress in patients with psoriasis vulgaris. Behav Brain Immun 21 (2007) 92-99
16. Schon M., Denzer D., Kubitza R.C., Ruzicka T., and Schon M.P. Critical role of neutrophils for the generation of psoriasiform skin lesions in flaky skin mice. J Invest Dermatol 114 (2000) 976-983
17. Madej A., Reich A., Orda A., and Szepietowski J.C. Vascular adhesion protein-1(VAP-1) is overexpressed in psoriatic patients. JEADV 21 (2007) 72-78
18. Yamasaki E., Soma Y., Kawa Y., and Mizoguchi M. Methotrexate inhibits proliferation and upregulation of intercellular adhesion molecule-1 and vascular adhesion molecule -1 by cultured huma umbilical vein endothelial cells. Br J Dermatol 149 (2003) 30-38
19. Hern S., Allen M.H., Sousa A.R., Harland C.C., Barker J.N., Levick J.R., et al. Immunohistochemical evaluation of psoriatic plaques following selective photothermolysis of the superficial capillaries. Br J Dermatol 145 (2001) 45-53
20. Abrams J.R., Kelley S.l., Hayes E., Kikuchi T., Brown M.J., Kang S., et al. Blockade of T lymphocyte costimulation with cytotoxic T lymphocyte-associated antigen4-immunoglobulin [CTLA4Ig]reverses the cellular pathology of psoriatic plaques, including the activation of keratinocytes, dendrotic cells, and endothelial cells. J Exp Med 4 (2000) 681-693
21. Gottlieb A.B., Miller B., Lowe N., Shapiro W., Hudson Ch., Bright R., et al. Subcutaneously administered efalizumab [anti-CD11a]improves signs and symptoms of moderate to severe plaque psoriasis. J Cutan Med Surg (2003) 198-207
22. Watabe D., Kanno H., Yoshida A., Kurose A., Akasaka T., and Sawai T. Adhesion of peripheral blood mononuclear cells and CD4+T cells from patients with psoriasis to cultured endothelial cells via interaction between lymphocyte function -associated antigen type 1 and intercellular adhesion molecule 1. Br J Dermatol 157 (2007) 259-265